ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)
US03635R2067 - ADR
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -120.09M | -80.57M | -101.62M | -42.30M | -39.32M | |||
| Depreciation Amortization | 3.91M | 3.10M | 2.66M | 3.14M | 2.29M | |||
| Income Taxes - Deferred | -1.18M | -90.00K | N/A | N/A | N/A | |||
| Change In Working Capital | -1.27M | 2.02M | 6.35M | 870.00K | 6.16M | |||
| Interest Paid | 2.19M | 2.41M | 1.03M | 890.00K | 1.23M | |||
| Other non cash items | 46.92M | 16.57M | 44.01M | 7.13M | 9.23M | |||
| OPERATING CASH FLOW | -71.71M | -58.97M | -48.60M | -31.15M | -21.64M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.97M | -2.49M | -3.16M | -2.85M | -2.62M | |||
| Other Investing Activity | 41.00K | 10.00K | -300.00K | 170.00K | -5.40M | |||
| INVESTING CASH FLOW | -3.93M | -2.48M | -3.46M | -2.68M | -8.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 32.24M | -6.17M | 6.00M | 11.95M | -2.00M | |||
| Stock Issued/Repurchased | 44.96M | 93.42M | 47.60M | -320.00K | 40.16M | |||
| Other Financing Activity | 6.22M | -26.32M | -7.49M | 24.65M | 1.65M | |||
| FINANCING CASH FLOW | 83.42M | 60.92M | 46.11M | 36.27M | 39.81M | |||
| Exchange Rate Effect | -1.54M | -2.58M | -810.00K | -970.00K | -2.89M | |||
| CHANGE IN CASH | 6.23M | -3.11M | -6.76M | 1.47M | 7.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -71.71M | -58.97M | -48.60M | -31.15M | -21.64M | |||
| Capital Expenditure | -3.97M | -2.49M | -3.16M | -2.85M | -2.62M | |||
| FREE CASH FLOW | -75.68M | -61.46M | -51.76M | -34.00M | -24.26M | |||
All data in CNY